# Clinical Study of Allergic Rhinitis Therapy by Stem Cells

> **NCT05151133** · PHASE1 · UNKNOWN · sponsor: **Yantai Yuhuangding Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **BIOLOGICAL:** Low dose UCMSCs
- **BIOLOGICAL:** Moderate dose UCMSCs
- **BIOLOGICAL:** High dose UCMSCs

## Key facts

- **NCT ID:** NCT05151133
- **Lead sponsor:** Yantai Yuhuangding Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-13
- **Primary completion:** 2024-12-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05151133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05151133, "Clinical Study of Allergic Rhinitis Therapy by Stem Cells". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05151133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*